Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile
(0)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company’s lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in clinical studies in systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus.

 

Click Here To Visit
500 River Ridge Drive
Second Floor
Norwood, MA United States
02062
CRBP

Ratings

There are no reviews yet.

Please login to rate this listing.
Close
Close